CA959844A - Process for producing non-hypnotic pure 5-allyl-5-(2-hydroxyethyl) barbituric acid, pharmaceutical preparation for therapeutic treatment, and method of carrying out therapeutic treatments - Google Patents

Process for producing non-hypnotic pure 5-allyl-5-(2-hydroxyethyl) barbituric acid, pharmaceutical preparation for therapeutic treatment, and method of carrying out therapeutic treatments

Info

Publication number
CA959844A
CA959844A CA142,967A CA142967A CA959844A CA 959844 A CA959844 A CA 959844A CA 142967 A CA142967 A CA 142967A CA 959844 A CA959844 A CA 959844A
Authority
CA
Canada
Prior art keywords
hypnotic
allyl
hydroxyethyl
pure
carrying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA142,967A
Other languages
English (en)
Other versions
CA142967S (en
Inventor
Jean Heusser
Max Glasbrenner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hommel AG
Original Assignee
Hommel AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hommel AG filed Critical Hommel AG
Application granted granted Critical
Publication of CA959844A publication Critical patent/CA959844A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/62Barbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA142,967A 1971-05-26 1972-05-25 Process for producing non-hypnotic pure 5-allyl-5-(2-hydroxyethyl) barbituric acid, pharmaceutical preparation for therapeutic treatment, and method of carrying out therapeutic treatments Expired CA959844A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH772871A CH551978A (de) 1971-05-26 1971-05-26 Verfahren zur herstellung reiner, von hypnotischen wirkungen freier 5-allyl-5-(2-hydroxyaethyl)-barbitursaeure.

Publications (1)

Publication Number Publication Date
CA959844A true CA959844A (en) 1974-12-24

Family

ID=4329579

Family Applications (1)

Application Number Title Priority Date Filing Date
CA142,967A Expired CA959844A (en) 1971-05-26 1972-05-25 Process for producing non-hypnotic pure 5-allyl-5-(2-hydroxyethyl) barbituric acid, pharmaceutical preparation for therapeutic treatment, and method of carrying out therapeutic treatments

Country Status (11)

Country Link
US (1) US3845209A (de)
JP (1) JPS528316B1 (de)
AT (1) AT320666B (de)
AU (1) AU451755B2 (de)
BE (1) BE783016A (de)
CA (1) CA959844A (de)
CH (1) CH551978A (de)
DE (1) DE2219647A1 (de)
ES (1) ES402553A1 (de)
FR (1) FR2157776B1 (de)
GB (1) GB1393942A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119350544B (zh) * 2024-12-20 2025-03-18 四川大学 汞离子响应型线性高分子和高分子智能凝胶及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1559552A (de) * 1961-05-08 1969-03-14

Also Published As

Publication number Publication date
DE2219647A1 (de) 1973-01-04
ES402553A1 (es) 1975-04-01
US3845209A (en) 1974-10-29
JPS528316B1 (de) 1977-03-08
FR2157776A1 (de) 1973-06-08
AU451755B2 (en) 1974-08-15
GB1393942A (en) 1975-05-14
AU4225972A (en) 1973-11-22
AT320666B (de) 1975-02-25
BE783016A (fr) 1972-09-01
CH551978A (de) 1974-07-31
FR2157776B1 (de) 1975-10-31

Similar Documents

Publication Publication Date Title
IE38602L (en) Aryloxyalkanolamine derivatives
CA982478A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
AU465949B2 (en) N-TERTIARY-4'-AMINOMETHYL-DIBENZO b,e-11-OXEPINE-2'-SPIRO-1',3'-DIOXOLANES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC APPLICATION
AU467578B2 (en) New cyclic urea derivatives and salts thereof process forthe production thereof and pharmaceutical preparations containing thesame
CA959844A (en) Process for producing non-hypnotic pure 5-allyl-5-(2-hydroxyethyl) barbituric acid, pharmaceutical preparation for therapeutic treatment, and method of carrying out therapeutic treatments
ZA727579B (en) Pyrimidin-6 yl acethydroxamid acids,their method of preparation and their therapeutic application
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
ZA751560B (en) Pyrimidin-6-yl acethydroxamic acids, their process of preparation and their therapeutic application
AU472168B2 (en) Treatment of titanium
GR61598B (en) Disubstituted phenolethers of 3-amino-2-hydroxypropan,preparation process thereof and use thereof as medicines
CA989307A (en) Agent for the treatment of hyperlipoproteinemias and process for the preparation thereof
AU3462171A (en) Process for the treatment and care of dentures
CA967483A (en) Dialysis process and apparatus for isolation of therapeutically active substances
AU474505B2 (en) Pharmaceutical composition containing 2-hydroxy-methyl-3-phenyl-4(3h)-quinazolinone or pharmaceutically acceptable acid salts thereof and method of treatment
CA875820A (en) Method and apparatus for preparing packages of yarn for subsequent treatment
ZA717597B (en) Pharmaceutical preparations for the treatment of pubertas praecox and a method of treating pubertas praecox
AU462834B2 (en) Pharmaceutical composition and method of treatment
AU457142B2 (en) Novel derivatives of 1 cinnamyl benzimidazole, their process of preparation and their therapeutic application
ZA737959B (en) New 4-ethers of 3-amino-5-sulfamoyl-benzoic acids,process for their manufacture and pharmaceutical preparations containing them
CA907436A (en) Mercaptoorganosilicone treated substrates and method of treatment and production
AU494192B2 (en) Anovel agent fob propylaxis and therapy of dehydrations in veterinary medicine, process for preparation and new use thereof
CA874951A (en) Process for preparing of a cream for treatment and regeneration of skin
AU4386772A (en) Improvements in or relating to novel compounds for the treatment of excess lipidic and cellulitic stresses, and process for preparing said compounds
AU7896175A (en) Anovel agent fob propylaxis and therapy of dehydrations in veterinary medicine, process for preparation and new use thereof
CA849490A (en) Method of treating skin injuries and a therapeutic composition for carrying out such treatment